Question 1

Does ExodusPoint Capital Management own NGNE stock?

Accepted Answer

No. ExodusPoint Capital Management exited its NGNE (Neurogene) position in Q1 2026. Its Q4 2025 13F listed 29,119 shares worth $599,851.

Question 2

How many shares of NGNE does ExodusPoint Capital Management own?

Accepted Answer

None since Q1 2026, when ExodusPoint Capital Management exited the position. Its Q4 2025 13F listed 29,119 shares worth $599,851.

Question 3

What is ExodusPoint Capital Management's NGNE position worth?

Accepted Answer

ExodusPoint Capital Management's NGNE position was worth $599,851 in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is ExodusPoint Capital Management buying or selling NGNE?

Accepted Answer

In Q1 2026, ExodusPoint Capital Management exited its entire NGNE position.

Question 5

When did ExodusPoint Capital Management first buy NGNE?

Accepted Answer

ExodusPoint Capital Management first reported NGNE in its Q4 2023 13F and listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$21.99	0
2025-Q4	Decreased	29,119	-10.5%	$599,851	0.0%	$22.11	0
2025-Q3	New	32,521	—	$563,589	0.0%	$17.71	34